730 Crystallization of Pharmaceutical and Biological Molecules II

Thursday, November 12, 2015: 3:15 PM - 5:45 PM
Ballroom D (Salt Palace Convention Center)

Description:
This session welcomes papers addressing fundamental as well as applied studies in the area of crystallization of pharmaceutical or biological molecules. Topics related to experimental studies, theory and simulation that contribute to fundamental understanding of crystallization as well as industrial case studies on the crystallization development of pharmaceutical and biological compounds are encouraged.

Sponsor:
Pharmaceutical Discovery, Development and Manufacturing Forum
Co-Sponsor(s):
Crystallization and Evaporation (02B), Pharmaceuticals (15B)
Chair:
Ryan C. Snyder Email: rcs048@bucknell.edu
Co-Chair:
David am Ende Email: david.j.amende@nalasengineering.com


3:15 PM
Introductory Remarks


3:20 PM
(730a) Development of a Reactive Slurry-Slurry Approach to Improve Crystallization Process Performance and Scalability
Lotfi Derdour, Joseph Reckamp and Christopher Pink


3:40 PM
(730b) Effect of Seed Type on the Resistance of API Agglomerates to Agitated Drying
Maria Sandoval, Lotfi Derdour, Saravanababu Murugesan, Christina Risatti, Alan Braem, Andrew G. Lee, Aghogho Pedro, Ehrlic T. Lo and Albert DelMonte


4:00 PM
(730c) Continuous Nanoparticle Production Using Focused Acoustics
Carl Beckett, Srikanth Kakumanu and Jim Laugharn


4:20 PM
(730d) Crystal Growth Inhibition of a Poorly Water-Soluble Drug Using Polymeric Additives
Caitlin Schram, Lynne Taylor and Stephen P. Beaudoin


4:40 PM
(730e) Dynamic Modeling and Control of Multi-Stage Slug-Flow Crystallization
Michael L. Rasche, Mo Jiang and Richard D. Braatz
See more of this Group/Topical: Pharmaceutical Discovery, Development and Manufacturing Forum
<< Previous Session | Next Session >>